48 related articles for article (PubMed ID: 10853714)
1. Composition of the microbiota in patients with growth hormone deficiency before and after treatment with growth hormone.
García Navas P; Ruíz Del Prado MY; Villoslada Blanco P; Recio Fernández E; Ruíz Del Campo M; Pérez Matute P
An Pediatr (Engl Ed); 2024 Jun; 100(6):404-411. PubMed ID: 38806303
[TBL] [Abstract][Full Text] [Related]
2. Impact of growth hormone status on body composition and the skeleton.
Mukherjee A; Murray RD; Shalet SM
Horm Res; 2004; 62 Suppl 3():35-41. PubMed ID: 15539797
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic aspects of growth hormone and insulin-like growth factor-I treatment on visceral fat and insulin sensitivity in adults.
Yuen KC; Dunger DB
Diabetes Obes Metab; 2007 Jan; 9(1):11-22. PubMed ID: 17199714
[TBL] [Abstract][Full Text] [Related]
4. Lack of reduction in body fat after treatment with insulin-like growth factor-I in two children with growth hormone gene deletions.
Arnhold IJ; Oliveira SB; Osorio MG; Carrilho AJ; Nicolau W; Bianco AC; Mendonca BB
J Endocrinol Invest; 2000 Apr; 23(4):258-62. PubMed ID: 10853714
[TBL] [Abstract][Full Text] [Related]
5. Influence of growth hormone on whole body and regional soft tissue composition in adult patients on hemodialysis. A double-blind, randomized, placebo-controlled study.
Hansen TB; Gram J; Jensen PB; Kristiansen JH; Ekelund B; Christiansen JS; Pedersen FB
Clin Nephrol; 2000 Feb; 53(2):99-107. PubMed ID: 10711411
[TBL] [Abstract][Full Text] [Related]
6. Effects of insulin-like growth factor I (IGF-I) therapy on body composition and insulin resistance in IGF-I gene deletion.
Woods KA; Camacho-Hübner C; Bergman RN; Barter D; Clark AJ; Savage MO
J Clin Endocrinol Metab; 2000 Apr; 85(4):1407-11. PubMed ID: 10770174
[TBL] [Abstract][Full Text] [Related]
7. Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency.
Thorén M; Hilding A; Baxter RC; Degerblad M; Wivall-Helleryd IL; Hall K
J Clin Endocrinol Metab; 1997 Jan; 82(1):223-8. PubMed ID: 8989263
[TBL] [Abstract][Full Text] [Related]
8. The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults.
Cuneo RC; Judd S; Wallace JD; Perry-Keene D; Burger H; Lim-Tio S; Strauss B; Stockigt J; Topliss D; Alford F; Hew L; Bode H; Conway A; Handelsman D; Dunn S; Boyages S; Cheung NW; Hurley D
J Clin Endocrinol Metab; 1998 Jan; 83(1):107-16. PubMed ID: 9435425
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone binding protein correlates strongly with leptin and percentage body fat in GH-deficient adults, is increased by GH replacement but does not predict IGF-I response.
Florkowski CM; Barnard R; Livesey JH; Veveris T; Espiner EA; Donald RA
Growth Horm IGF Res; 1999 Feb; 9(1):35-40. PubMed ID: 10207506
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor-I treatment in two children with growth hormone gene deletions.
Arnhold IJ; Oliveira SB; Osorio MG; Mendonca BB
J Pediatr Endocrinol Metab; 1999; 12(4):499-506. PubMed ID: 10417965
[TBL] [Abstract][Full Text] [Related]
11. Effects of insulin-like growth factor I treatment on statural growth, body composition and phenotype of children with growth hormone insensitivity syndrome. GHIS Collaborative Group.
Underwood LE; Backeljauw P; Duncan V
Acta Paediatr Suppl; 1999 Feb; 88(428):182-4. PubMed ID: 10102077
[TBL] [Abstract][Full Text] [Related]
12. Action of growth hormone in adipose tissue.
Richelsen B
Horm Res; 1997; 48 Suppl 5():105-10. PubMed ID: 9434054
[TBL] [Abstract][Full Text] [Related]
13. Changes in bone mineral density, body composition, and lipid metabolism during growth hormone (GH) treatment in children with GH deficiency.
Boot AM; Engels MA; Boerma GJ; Krenning EP; De Muinck Keizer-Schrama SM
J Clin Endocrinol Metab; 1997 Aug; 82(8):2423-8. PubMed ID: 9253311
[TBL] [Abstract][Full Text] [Related]
14. Determinants of body composition measured by dual-energy X-ray absorptiometry in Dutch children and adolescents.
Boot AM; Bouquet J; de Ridder MA; Krenning EP; de Muinck Keizer-Schrama SM
Am J Clin Nutr; 1997 Aug; 66(2):232-8. PubMed ID: 9250099
[TBL] [Abstract][Full Text] [Related]
15. Plasma cholesteryl ester transfer protein is lowered by treatment of hypercholesterolemia with cholestyramine.
Carrilho AJ; Medina WL; Nakandakare ER; Quintão EC
Clin Pharmacol Ther; 1997 Jul; 62(1):82-8. PubMed ID: 9246022
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
